Disturbed glucose disposal in patients with major depression; application of the glucose clamp technique

Psychosomatic Medicine

Volumn 70, Issue 2, 2008, Pages 170-176

  Schweiger, Ulrich ^a   Greggersen, Wiebke ^a   Rudolf, Sebastian ^a   Pusch, Matthias ^a   Menzel, Tilmann ^a   Winn, Sebastian ^a   Hassfurth, Jan ^a   Fassbinder, Eva ^a   Kahl, Kai G ^a   Oltmanns, Kerstin M ^a   Hohagen, Fritz ^a   Peters, Achim ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cortisol; Depressive disorder; Glucose clamp technique; Insulin; Norepinephrine; Vascular endothelial growth factor

Indexed keywords

C PEPTIDE; CORTICOTROPIN; GLUCOSE; HYDROCORTISONE; INSULIN; NORADRENALIN; VASCULOTROPIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL;

EID: 39149140669     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318164231d     Document Type: Article

References (33)

1. McCowan PK, Quastel JH. Blood-sugar studies in abnormal mental states. J Ment Sci 1931;77:525-48.
2. Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988;145:325-30.
3. Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired glucose tolerance. Exp Clin Endocrinol Diabetes 2000;108:187-90.
4. Freeman H. Resistance to insulin in mentally disturbed soldiers. Arch Neurol Psychiatry 1946;56:74-8.
5. Sachar EJ, Finkelstein J, Hellman L. Growth hormone response in depressive illness. I. Response to insulin tolerance test. Arch Gen Psychiatry 1971;25:263-9.
6. Casper RC, Davis JM, Pandey GN, Garver DL, Dekirmenjian H. Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology 1977;2:105-13.
7. Deuschle M, Schweiger U, Weber B, Gotthardt U, Körner A, Schmider J, Standhardt H, Lammers CH, Heuser I. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 1997;82:234-8.
8. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005;19:113-22.
9. Defronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
10. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.
11. Beysen C, Murphy EJ, McLaughlin T, Riiff T, Lamendola C, Turner HC, Awada M, Turner SM, Reaven G, Hellerstein MK. Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo. Diabetes Care 2007; 30:1143-9.
12. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991;260:E67-E74.
13. Sullivan PF, Prescott CA, Kendler KS. The subtypes of major depression in a twin registry. J Affect Disord 2002;68:273-84.
14. Stunkard AJ, Fernstrom MH, Price A, Frank E, Kupfer DJ. Direction of weight change in recurrent depression. Consistency across episodes. Arch Gen Psychiatry 1990;47:857-60.
15. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002;7:254-75.
16. Kim J, Saidel GM, Cabrera ME. Multi-scale computational model of fuel homeostasis during exercise: effect of hormonal control. Ann Biomed Eng 2007;35:69-90.
17. Madsen PL, Hasselbalch SG, Hagemann LP, Olsen KS, Bulow J, Holm S, Wildschiodtz G, Paulson OB, Lassen NA. Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 1995;15:485-91.
18. Boyle PJ, Scott JC, Krentz AJ, Nagy RJ, Comstock E, Hoffman C. Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 1994;93:529-35.
19. Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005;62:397-408.
20. Baxter LR, Jr, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry 1985;42:441-7.
21. Hundal O. Major depressive disorder viewed as a dysfunction in astroglial bioenergetics. Med Hypotheses 2007;68:370-377.
22. Zethelius B, Lithell H, Hales CN, Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 2005;48:862-7.
23. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA 2005;294:334-41.
24. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004;66:316-22.
25. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000;160:1261-8.
26. Peters A, Pellerin L, Dallman MF, Oltmanns KM, Schweiger U, Born J, Fehm HL. Causes of obesity: looking beyond the hypothalamus. Prog Neurobiol 2007;81:61-88.
27. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991;88:168-73.
28. Sigal RJ, El Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH. Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes 1997;46:1025-9.
29. Odeleye OE, de Court, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997;46:1341-5.
30. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, Fehm HL, Peters A. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 2002;87:835-40.
31. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 2000;97:10242-7.
32. Breum L, Bjerre U, Bak JF, Jacobsen S, Astrup A. Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism 1995;44:1570-6.
33. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 2006;5:157-168.